Ovid Therapeutics Inc.Ovid Therapeutics Inc.Ovid Therapeutics Inc.

Ovid Therapeutics Inc.

No trades
See on Supercharts
Market capitalization
‪224.15 M‬USD
−0.74USD
‪−52.34 M‬USD
‪391.70 K‬USD
‪58.56 M‬
Beta (1Y)
0.70

About Ovid Therapeutics Inc.

CEO
Jeremy Max Levin
Headquarters
New York
Website
Employees (FY)
40
Founded
2014
ISIN
US6904691010
FIGI
BBG009F0TD76
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OVID is 3.17 USD — it has decreased by 0.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ovid Therapeutics Inc. stocks are traded under the ticker OVID.
Ovid Therapeutics Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Ovid Therapeutics Inc. has a max estimate of 11.00 USD and a min estimate of 7.00 USD.
OVID earnings for the last quarter are −0.16 USD whereas the estimation was −0.19 USD which accounts for 13.72% surprise. Estimated earnings for the next quarter are −0.05 USD. See more details about Ovid Therapeutics Inc. earnings.
Ovid Therapeutics Inc. revenue for the last quarter amounts to ‪108.97 K‬ USD despite the estimated figure of ‪45.83 K‬ USD. In the next quarter revenue is expected to reach ‪8.62 M‬ USD.
Yes, you can track Ovid Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, OVID shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ovid Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
OVID reached its all-time high on May 18, 2017 with the price of 15.93 USD, and its all-time low was 1.41 USD and was reached on Nov 8, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 17, 2024, the company has 40.00 employees. See our rating of the largest employees — is Ovid Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ovid Therapeutics Inc. EBITDA is ‪−57.68 M‬ USD, and current EBITDA margin is ‪−14.73 K‬%. See more stats in Ovid Therapeutics Inc. financial statements.